Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like Vertex Quietly Terminates a Small Phase II CF Trial September 11, 2017 XW Laboratories Inc. Secures Over $17M Series B Financing Led By And September 19, 2017 <b>SGI-DNA</b> Launches Automated Next-Generation Sequencing Library Construction Kits For The BioXp 3200 System To Expand The Capabilities Of The Genomic Workstation March 28, 2017
<b>SGI-DNA</b> Launches Automated Next-Generation Sequencing Library Construction Kits For The BioXp 3200 System To Expand The Capabilities Of The Genomic Workstation March 28, 2017
